{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:10:09Z","timestamp":1760062209456,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ejso.2020.04.012","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T01:56:27Z","timestamp":1586829387000},"page":"1315-1319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Isolated limb perfusion is an effective treatment modality for locally advanced Kaposi sarcoma of the extremities"],"prefix":"10.1016","volume":"46","author":[{"given":"T.","family":"Boere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.A.","family":"Huis in \u2019t Veld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Deroose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.M.","family":"van Ginhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.W.J.M.","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.J.","family":"Gr\u00fcnhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.J.","family":"van Houdt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejso.2020.04.012_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199607253350403","article-title":"Seroconversion to antibodies against kaposi's sarcoma\u2013associated herpesvirus\u2013related latent nuclear antigens before the development of kaposi's sarcoma","volume":"335","author":"Gao","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ejso.2020.04.012_bib2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nm0896-925","article-title":"KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma","volume":"2","author":"Gao","year":"1996","journal-title":"Nat Med"},{"issue":"14","key":"10.1016\/j.ejso.2020.04.012_bib3","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJM199804023381403","article-title":"Sexual transmission and the natural history of human","volume":"338","author":"Martin","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2020.04.012_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/modpathol.2008.15","article-title":"Classic Kaposi Sarcoma in the United States over the last two decades: a clinicopathologic and molecular study of 438 non-HIV-related Kaposi Sarcoma patients with comparison to HIV-related Kaposi Sarcoma","author":"Hiatt","year":"2008","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.ejso.2020.04.012_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000227312","article-title":"Endemic african kaposi's sarcoma: clinical and therapeutic implications: 10-year experience in the johannesburg hospital (1980-1990)","volume":"51","author":"Stein","year":"1994","journal-title":"Oncology"},{"issue":"9","key":"10.1016\/j.ejso.2020.04.012_bib6","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1016\/j.transproceed.2014.09.165","article-title":"Incidence and management of Kaposi sarcoma in renal transplant recipients: the Greek experience","volume":"46","author":"Zavos","year":"2014","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1016\/j.ejso.2020.04.012_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0002-9343(88)90418-4","article-title":"Kaposi's sarcoma: the most common tumor after renal transplantation in Saudi Arabia","volume":"84","author":"Wajeh","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.ejso.2020.04.012_bib8","first-page":"339","article-title":"Kaposi's sarcoma in organ transplant recipients. the collaborative transplantation research group of ile de france","volume":"2","author":"Farge","year":"1993","journal-title":"Eur J Med"},{"key":"10.1016\/j.ejso.2020.04.012_bib9","article-title":"Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California","author":"Center for Disease Control","year":"1981","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.ejso.2020.04.012_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaad.2008.05.001","article-title":"Kaposi sarcoma: a continuing conundrum","volume":"59","author":"Schwartz","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.ejso.2020.04.012_bib11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.canep.2014.09.009","article-title":"Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project","volume":"38","author":"Stiller","year":"2014","journal-title":"Canc Epidemiol"},{"key":"10.1016\/j.ejso.2020.04.012_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/modpathol.3800061","article-title":"Immunohistochemical detection of human herpes virus-8 latent nuclear antigen-1 is useful in the diagnosis of Kaposi sarcoma","author":"Patel","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejso.2020.04.012_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/1471-5945-11-15","article-title":"Classic Kaposi's sarcoma in Morocco: clinico -epidemiological study at the national institute of oncology","author":"Errihani","year":"2011","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.ejso.2020.04.012_bib14","series-title":"International journal of dermatology","article-title":"Classic Kaposi's sarcoma in Greece: a clinico-epidemiological profile","author":"Stratigos","year":"1997"},{"key":"10.1016\/j.ejso.2020.04.012_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2018.12.036","article-title":"Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF\/EADO\/EORTC)","author":"Lebbe","year":"2019","journal-title":"Eur J Canc"},{"issue":"2","key":"10.1016\/j.ejso.2020.04.012_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1742-481X.2010.00763.x","article-title":"Clinical challenge: cutaneous Kaposi's sarcoma of the lower extremity","volume":"8","author":"Johnson","year":"2011","journal-title":"Int Wound J"},{"key":"10.1016\/j.ejso.2020.04.012_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2014.11.020","article-title":"Treatment modifications in tumour necrosis factor-\u03b1 (TNF)-based isolated limb perfusion in patients with advanced extremity soft tissue sarcomas","author":"Deroose","year":"2015","journal-title":"Eur J Canc"},{"issue":"4","key":"10.1016\/j.ejso.2020.04.012_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ejso.2012.12.018","article-title":"Outcomes of isolated limb perfusion in the treatment of extremity soft tissue sarcoma: a systematic review","volume":"39","author":"Bhangu","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.04.012_bib19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1245\/s10434-015-4856-x","article-title":"Isolated limb perfusion with melphalan and tumour necrosis factor \u03b1 for in-transit melanoma and soft tissue sarcoma","volume":"22","author":"Smith","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.04.012_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/02656736.2015.1101170","article-title":"Hyperthermic isolated limb perfusion in locally advanced limb soft tissue sarcoma: a 24-year single-centre experience","volume":"32","author":"Rastrelli","year":"2016","journal-title":"Int J Hyperther"},{"key":"10.1016\/j.ejso.2020.04.012_bib21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2017.07.023","article-title":"Isolated limb perfusion for locally advanced angiosarcoma in extremities: a multi-centre study","volume":"85","author":"Huis Veld","year":"2017","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejso.2020.04.012_bib22","first-page":"1","article-title":"Isolated limb perfusion for unresectable extremity cutaneous squamous cell carcinoma; an effective limb saving strategy","author":"Huis In T Veld","year":"2018","journal-title":"Br J Canc"},{"key":"10.1016\/j.ejso.2020.04.012_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/00000658-199612000-00011","article-title":"Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas: the cumulative multicenter European experience","author":"Eggermont","year":"1996","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2020.04.012_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archsurg.134.2.177","article-title":"Isolated limb perfusion with high-dose tumor necrosis factor and melphalan for Kaposi sarcoma","volume":"134","author":"Lev-Chelouche","year":"1999","journal-title":"Arch Surg"},{"key":"10.1016\/j.ejso.2020.04.012_bib25","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-017-5803-9","article-title":"Isolated limb perfusion for melanoma is safe and effective in elderly patients","author":"Madu","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.04.012_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.7621","article-title":"Long-term outcome of isolated limb perfusion with tumour necrosis factor-?? for patients with melanoma in-transit metastases","author":"Deroose","year":"2011","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.ejso.2020.04.012_bib27","article-title":"WHO handbook for reporting results of cancer treatment","volume":"38","author":"Hunter","year":"1980","journal-title":"Int J Radiat Biol"},{"issue":"10","key":"10.1016\/j.ejso.2020.04.012_bib28","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","article-title":"Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions","volume":"18","author":"Wieberdink","year":"1982","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2020.04.012_bib29","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/jso.23591","article-title":"Oncological outcome of primary non-metastatic soft tissue sarcoma treated by neoadjuvant isolated limb perfusion and tumor resection","volume":"109","author":"Jakob","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2020.04.012_bib30","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s12094-019-02034-w","article-title":"Neoadjuvant isolated limb perfusion in newly diagnosed untreated patients with locally advanced soft tissue sarcomas of the extremities: the Gustave Roussy experience","volume":"21","author":"Assi","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ejso.2020.04.012_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2016.09.021","article-title":"Isolated limb perfusion for the management limb threatening soft tissue sarcomas: the role of histological type on clinical outcomes","author":"Rastrelli","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.04.012_bib32","article-title":"Efficacy of repeat isolated limb perfusions with tumor necrosis factor \u03b1 and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure","author":"Gr\u00fcnhagen","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.04.012_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/CMR.0000000000000177","article-title":"Repeated isolated limb perfusion in melanoma patients with recurrent in-transit metastases","author":"Deroose","year":"2015","journal-title":"Melanoma Res"},{"issue":"4","key":"10.1016\/j.ejso.2020.04.012_bib34","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2133.2009.09601.x","article-title":"Intralesional vincristine as first-line therapy for nodular lesions in classic Kaposi sarcoma: a prospective study in 151 patients","volume":"162","author":"Brambilla","year":"2010","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.ejso.2020.04.012_bib35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jaad.2012.04.018","article-title":"Treatments for classic Kaposi sarcoma: a systematic review of the literature","volume":"68","author":"R\u00e9gnier-Rosencher","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.ejso.2020.04.012_bib36","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1200\/JCO.1998.16.7.2445","article-title":"Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial","volume":"16","author":"N","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.04.012_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1468-3083.2007.02405.x","article-title":"Radiotherapy of classic and human immunodeficiency virus-related Kaposi's sarcoma: results in 1482 lesions","volume":"22","author":"Caccialanza","year":"2008","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.ejso.2020.04.012_bib38","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/dsu.12285","article-title":"Evaluation of effectiveness of cryotherapy on the treatment of cutaneous kaposi's sarcoma","volume":"39","author":"Kutlubay","year":"2013","journal-title":"Dermatol Surg"},{"issue":"5","key":"10.1016\/j.ejso.2020.04.012_bib39","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0360-3016(88)90196-4","article-title":"The influence of dose on the long-term control of classic (non-aids associated) Kaposi's sarcoma by radiotherapy","volume":"15","author":"Cooper","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"year":"2017","series-title":"Classic Kaposi sarcoma: clinical features, staging, diagnosis and treatment","author":"Krown","key":"10.1016\/j.ejso.2020.04.012_bib40"},{"key":"10.1016\/j.ejso.2020.04.012_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/j.1346-8138.1992.tb03727.x","article-title":"Classic Kaposi's sarcoma: a review of 90 cases","author":"Zurrida","year":"1992","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.ejso.2020.04.012_bib42","doi-asserted-by":"crossref","DOI":"10.1158\/1055-9965.EPI-08-0671","article-title":"Risk factors for classical Kaposi sarcoma in a population-based case-control study in sicily","author":"Anderson","year":"2008","journal-title":"Canc Epidemiol Biomarkers Prev"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320304091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320304091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:33:18Z","timestamp":1760059998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320304091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0748798320304091"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.04.012","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isolated limb perfusion is an effective treatment modality for locally advanced Kaposi sarcoma of the extremities","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}